Gyre Therapeutics
GYRE
GYRE
47 hedge funds and large institutions have $25.1M invested in Gyre Therapeutics in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
47
Holders Change
+1
Holders Change %
+2.17%
% of All Funds
0.63%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
25
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
BlackRock
New York
|
+$2.17M |
2 |
SS
SBI Securities
Tokyo,
Japan
|
+$799K |
3 |
Geode Capital Management
Boston,
Massachusetts
|
+$657K |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$391K |
5 |
State Street
Boston,
Massachusetts
|
+$360K |
Top Sellers
1 |
Goldman Sachs
New York
|
-$125K |
2 |
UBS Group
Zurich,
Switzerland
|
-$115K |
3 |
AACP
Advantage Alpha Capital Partners
San Francisco,
California
|
-$105K |
4 |
American Century Companies
Kansas City,
Missouri
|
-$92.1K |
5 |
CF
Corebridge Financial
Houston,
Texas
|
-$26.4K |